Xiamen Amoytop Biotech Co., Ltd.
SSE:688278.SS
73.64 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 827.602 | 555.449 | 287.02 | 181.201 | 116.57 | 64.294 | 16.003 | 5.169 | 29.314 |
| Depreciation & Amortization
| 93.445 | 68.219 | 48.075 | 43.152 | 38.168 | 37.777 | 37.542 | 25.737 | 17.23 |
| Deferred Income Tax
| 0 | 0 | -2.608 | -7.522 | 0.087 | 2.251 | -16.308 | -1.196 | -5.011 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -480.902 | -121.079 | 30.529 | 14.989 | -61.668 | 15.248 | 33.309 | -49.494 | -13.469 |
| Accounts Receivables
| -404.827 | -205.756 | -15.513 | -24.538 | -42.419 | 9.062 | -1.138 | -36.094 | -37.088 |
| Inventory
| -76.529 | -57.29 | -13.237 | -16.871 | -29.024 | -15.316 | -13.861 | -10.379 | -0.067 |
| Accounts Payables
| 0 | 153.191 | 61.887 | 63.92 | 9.688 | 19.251 | 64.616 | -1.825 | 28.698 |
| Other Working Capital
| 0.453 | -11.224 | -2.608 | -7.522 | 0.087 | 2.251 | 47.169 | -39.115 | -13.401 |
| Other Non Cash Items
| -9.512 | 9.511 | -2.463 | -4.562 | -0.462 | 5.982 | 2.293 | 7.182 | 9.352 |
| Operating Cash Flow
| 430.633 | 512.101 | 363.161 | 234.781 | 92.608 | 123.301 | 89.147 | -11.405 | 42.427 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -251.353 | -288.461 | -219.168 | -190.926 | -118.81 | -44.826 | -14.6 | -26.891 | -87.032 |
| Acquisitions Net
| 0 | 0 | 0.107 | 0.34 | 118.868 | 0.095 | 0.055 | 0 | 0.091 |
| Purchases Of Investments
| -696.412 | -616 | -700 | -754.574 | -1,148.1 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 639.121 | 598.653 | 629.662 | 833.318 | 884.86 | 0 | 0 | 0 | 0.004 |
| Other Investing Activites
| 0.028 | 0.044 | 0 | 0 | -118.81 | -44.826 | 0.055 | -26.891 | 1.091 |
| Investing Cash Flow
| -308.617 | -305.765 | -289.399 | -111.843 | -381.993 | -44.731 | -14.545 | -26.891 | -85.937 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | -10 | -8.918 | 0 | -10 | -10 | -5 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | -13.241 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -166.788 | -86.648 | -40.68 | -20.34 | -10.17 | -3.391 | -3.759 | -4.023 | -4.543 |
| Other Financing Activities
| -6.229 | -6.262 | -7.688 | -4.609 | 293.838 | -4.474 | -0 | -3.27 | 130.96 |
| Financing Cash Flow
| -173.017 | -92.91 | -58.368 | -34.202 | 281.114 | -17.865 | -13.759 | -12.293 | 126.417 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.135 | -1.106 | 0.028 | -0.486 | -0.956 | 0.117 | 0.398 | -0.25 | 0.168 |
| Net Change In Cash
| -51.135 | 112.32 | 15.421 | 88.251 | -9.227 | 60.822 | 61.24 | -50.84 | 83.075 |
| Cash At End Of Period
| 361.516 | 412.651 | 300.331 | 284.91 | 196.659 | 205.886 | 145.064 | 83.823 | 134.663 |